Overview and details of the sessions of this conference. Please select a date or room to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).
Early Morning 2A: Assessment, pricing, and reimbursement of new health technologies
Objectives: In this session, we will a) outline key questions for decision making on providing affordable access to novel, high-cost medicines in health systems; b) illustrate assessments of the value of medicines as a basis for decision making; and c) describe innovative reimbursement models for high-cost medicines in health systems. Through discussion with the audience, we will generate a list of questions for future research on access to new health technologies.
Affordable, Appropriate Access to High-cost Medicines: Key Issues in Latin America
Pan American Health Organization, United States of America
Health Technology Assessment: Policies and Practices in Europe
Main Association of Austrian Social Security Institutions, Austria
Innovative Pricing Models: Examples from Health Insurance Systems in Asia
Novartis Pharma AG, Switzerland